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JNKHyperglycemia signiﬁcantly stimulates pancreatic islet endothelial cell apoptosis; however, the precise
mechanisms are not fully understood. In the present study, treating pancreatic islet endothelial (MS-1) cells
with high glucose (30 mmol/l) but not mannitol signiﬁcantly increased the number of apoptotic cells as
compared with a physiological glucose concentration (5.5 mmol/l). Hyperglycemia signiﬁcantly stimulated
the expression of inducible nitric oxide synthase (iNOS) and production of NO and peroxynitrite (ONOO−),
relevant to MS-1 cell apoptosis. Moreover, induced reactive nitrogen species (RNS) signiﬁcantly increased the
expression of bax, cleaved caspase-3 and poly adenosine diphosphate (ADP)-ribose polymerase (PARP) via
JNK activation, but the expression of bcl-2 was not altered. Furthermore, SP600125 (a speciﬁc inhibitor of JNK)
and 1400W (a speciﬁc inhibitor of iNOS) signiﬁcantly attenuated cell apoptosis induced by high glucose.
Therefore, hyperglycemia triggers MS-1 cell apoptosis by activating an intrinsic-dependent apoptotic
pathway via RNS-mediated JNK activation.u Hospital, Jinan, No.107, Wen
X. Zhang),
l rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Introduction
Pancreatic islets in the adult are one of the most vascularized
organs and have a unique glomerular-like structural feature [1]. Β cells
are surrounded by islet endothelial cells (ECs) in a cross-talk
relationship, so these cells are exposed to each other's secretions.
Vascular endothelial growth factor-A secreted by B cells is responsible
for the formation of a dense capillary network in islets and the
phenotype of the islet EC, showing an increased number of
fenestrations [1,2]. Recent studies indicate that the islet ECs likely
play a pivotal role inmaintaining physiologic function and accelerating
disease of the pancreatic islets. Islet ECs are important in thedelivery of
oxygen, nutrients, cytokines, and secretory signals to endocrine cells
[3,4] and induce insulin gene expression during pancreatic islet
development [5]. Moreover, some studies support that islet ECs may
participate in adult B-cell function and promote B-cell proliferation
mediated by hepatocyte growth factor [6] and laminins [7]. Study of a
type 2 diabetes model revealed that morphological or metabolic
changes in islet vasculature may affect the B-cell microenvironmentand contribute to B-cell failure, which plays a key role in the
development of diabetes [8,9].
The above studies indicate that a normal pancreatic endocrine
vasculature is essential for B-cell function. Hyperglycemia induces
macro- andmicrovascular EC apoptosis via activation of Jun N-terminal
kinase (JNK) and caspase-3 [10], tyrosine nitration caused by perox-
ynitrite [11], reactive nitrogen species (RNS)-mediated Akt signaling
[12], and forkhead box O1 activation [13]. However, studies of the
apoptosis of islet ECs are lacking. A recent study indicated that
hyperglycemia induces apoptosis of human pancreatic islet ECs and
that pravastatin (3-hydroxy-3-methylglutaryl coenzyme A inhibitor)
may improve vascular function bymodulating the phosphatidylinositol
3-kinase (PI3K)/Akt pathway [14]. Moreover, islet ECs can glucose-
dependently secrete cytokines and NO by activating inducible NO
synthase (iNOS) [14,15]. However, lowconcentrationsofNO canprotect
cells against apoptosis, and high concentrations promote cell death in
various cell types [16].
The pathogenesis of islet EC apoptosis induced by hyperglycemia
involves multiple mechanisms. Several studies demonstrate that EC
apoptotic pathways include the mitogen-activated protein kinase
(MAPK) signaling [10,17]. MAPKs include 4 subfamily members—
extracellular signal-regulated kinase 1/2 (ERK1/2), Jun N-terminal
kinase (JNK), p38 MAPK, and ERK5—which mediate cellular processes
such as proliferation, differentiation, apoptosis, and development in
response to various stimuli. Earlier studies demonstrated that the
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hyperglycemia [10,17]. However, which molecules or pathways are
involved in islet EC apoptosis induced by hyperglycemia is unclear.
In thepresent study,we analyzed theeffects of hyperglycemia on islet
EC apoptosis and evaluated the production of iNOS, NO and ONOO−. In
addition, we investigated whether the JNK pathway or an intrinsic-
dependent apoptotic pathway plays a role in islet EC apoptosis.We show
that hyperglycemia induces apoptosis of pancreatic islet ECs via an
intrinsic-dependent apoptotic pathway by RNS-mediated JNK activation.
2. Materials and methods
2.1. Reagents
The antibodies against cleaved caspase-3, cleaved poly adenosine
diphosphate (ADP)-ribose polymerase (PARP), phospho-JNK, total-
JNK and all secondary antibodieswere from Cell Signaling Technology.
Antibody to iNOS was from Santa Cruz Biotechnology. Nitrotyrosine
monoclonal antibody was from Cayman. SP600125 was from GIBCO.
Kits for annexin V-FITC apoptosis detection, Hoechst staining,
Caspase-3 activity assay, reactive oxygen species assay, superoxide
anion assay and total NO assay, as well as antibodies against bax, bcl-2
and other chemicals, were from Beyotime (Shanghai).
2.2. Cell culture
MS-1 cells (a pancreatic islet EC line, purchased from ATCC, ATCC®
Number: CRL-2279™. Source: Organ: pancreas , Strain: C57BL/6 , Tissue:
islet of Langerhans; endothelium , Cell Type: SV40 transformed) were
cultured in Dulbecco's modiﬁed Eagle's medium (low glucose,
5.5 mmol/l) containing 5% fetal bovine serum (FBS), 100 U/ml penicillin
and 100 μg/ml streptomycin in a humidiﬁed atmosphere with 5% CO2 at
37 °C. Cells at passages 4–8 were used. MS-1 cells were exposed to
normal glucose (5.5 mmol/l glucose), hyperosmotic control (5.5 mmol/l
glucose plus 24.5 mmol/l mannitol) or high glucose (30 mmol/l glucose)
for 7 days with a daily change of culture media. When needed, the
pharmacological inhibitors SP600125 (an inhibitor of JNK, 30 μmol/l) and
1400W (an inhibitor of iNOS, 20 μmol/l) were preincubated 1 h before
high glucose.
2.3. Immunocytochemistry
Cells were plated on 24-well plates. After treatment, cells were
washed 3 times with ice-cold PBS and ﬁxed with acetone and
methanol (1:1), then stained with 10 μg/ml Hoechst 33258 for
10 min. Apoptotic cells were counted in random ﬁelds by laser
scanning confocal microscopy; each experiment was performed in
triplicate (×40 magniﬁcation, at least 10 ﬁelds per sample).
2.4. Flow cytometry
Cells were plated on 6-well plates. After treatment, cells were
stained with annexin-V and propidium iodide (PI) for 10 min at room
temperature in the dark. The level of apoptosis was measured by ﬂow
cytometry within 30 min.
2.5. Caspase-3 activity assay
Caspase-3 activity was determined with a Caspase-3 activity assay
Kit (Beyotime, China). Under the Caspase-3, acetyl-Asp-Glu-Val-Asp
p-nitroanilide (Ac-DEVD-pNA) can be changed into the yellow
product, p-nitroaniline(pNA), which was measured using the spec-
trophotometer at an absorbance of 405 nm. After treatment, MS-1
cells were harvested, and the Caspase-3 activity was measured by use
of the kit according to the manufacturer's instructions.2.6. Intracellular reactive oxygen species (ROS) and superoxide anion
(O2
−) production assay
Cells in 24-well plates were incubated with normal glucose,
hyperosmotic control or high glucose for 7 days, then washed twice
with PBS and incubated with 2′,7′-dichloroﬂuorescein diacetate
(DCFH-DA) for 20 min at 37 °C. The ROS level was determined on the
oxidative conversion of DCFH-DA to ﬂuorescent dichloroﬂuorescein on
reaction with ROS in cells. After treatment, cells in 24-well plates were
incubated with dihydroethidium (ﬂuorescent probe of O2−) for 30 min
at 37 °C. After awashingwith PBS,ﬂuorescent signals (ROS, 488 nm;O2−,
535 nm) were recorded by laser scanning confocal microscopy. The
ﬂuorescence intensity of random ﬁelds wasmeasured (at least 10 ﬁelds
per sample). Three independent experiments were performed.
2.7. Immunohistochemistry
Cells cultured on glass coverslips were ﬁxed in 4% paraformalde-
hyde for 20 min, permeabilized in 0.03% Triton X-100 for 5 min,
blocked in 10% bovine serum albumin for 1 h at room temperature,
then incubated with the primary antibodies overnight at 4 °C, then a
secondary antibody.
2.8. Western blot analysis
After treatment, MS-1 cells were harvested with use of a lysis buffer
containing protease inhibitors. Proteins were separated by 10% SDS-
PAGE and transferred onto polyvinylidene ﬂuoride membranes.
Membranes were blocked with 5% non-fat milk for 2 h at room
temperature. Protein was incubated with primary antibodies overnight
at 4 °C and horseradish peroxidase-conjugated secondary antibodies for
2 h at room temperature. After a washing with TBS-Tween (15 min, 3
times), membranes underwent detection by enhanced chemilumines-
cence (Millipore).
2.9. NO measurement
Levels of NO were detected by modiﬁed Griess reaction, based on
total concentrations of NO stable end products, nitrite and nitrate. The
culture medium was harvested, and the concentrations of NO2− and
NO3− were measured by use of a total NO assay kit (Beyotime)
according to the manufacturer's instructions and analyzed on a plate
reader at 540 nm.
2.10. Statistical analysis
All results were presented as means±S.D. of 3 independent
experiments. Differences between groups were evaluated by one-way
ANOVA. Pb0.05 was considered statistically signiﬁcant.
3. Results
3.1. Inhibition of JNK or iNOS attenuates hyperglycemia-induced MS-1
cell apoptosis
First, we examined the effects of high glucose treatment on
apoptosis of MS-1 cells by annexin-V and PI double staining. The
percentage apoptosis of cells was greater with high glucose
(30 mmol/l) than with normal glucose (5.5 mmol/l) (15.2% vs. 8.1%;
Pb0.05) after 7 days (Fig. 1A, B); the apoptotic rate of hyperosmotic
controls (5.5 mmol/l glucose plus 24.5 mmol/l mannitol) did not
differ from controls. Therefore, MS-1 cell apoptosis was attributable to
the cytotoxicity of the high glucose concentration but not high
osmolarity. Similar results were obtained by Hoechst 33258 staining:
the percentage apoptosis of cells was greater with high than normal
glucose level (19.2% vs. 7.3%; Pb0.05) but not a high concentration of
Fig. 1. Effects of Jun N-terminal kinase (JNK) inhibitor SP600125 or inducible nitric oxide synthase (iNOS) inhibitor 1400W onMS-1 cell apoptosis under high glucose. MS-1 cells were
pretreatedwith orwithout SP600125 (30 μmol/l) or 1400W (20 μmol/l) for 1 h before exposure to normal glucose (5 mmol/l) or high glucose (30 mmol/l) for 7 days. (A) Cell apoptosis
wasdeterminedbyannexin-V andpropidium iodide (PI) double stainingonﬂowcytometry. (B) Thenumberof annexin-V-positive cellswasquantiﬁed (n=5,means±S.D.). *Pb0.05vs.
5.5 mM, #Pb0.05 vs. 30 mM. (C) Morphologic changes in nuclei of MS-1 cells assessed by Hoechst 33258 staining. Arrows indicate apoptotic cells. (D) The number of apoptotic cells
stained by Hoechst 33258 was quantiﬁed in at least 10 ﬁelds per sample (n=3, means±S.D.). *Pb0.05 vs. 5.5 mM, #Pb0.05 vs. 30 mM. (E) Caspase-3 activity of MS-1 cells at different
time points in the previous 2 days. (n=3, means±S.D.). *Pb0.05 vs. 5.5 mM, #Pb0.05 vs. 30 mM. Mannitol=MS-1 cells maintained under high mannitol (5.5 mmol/l glucose plus
24.5 mmol/l mannitol). The assays were performed after 7 days' treatment. Bar=20 μm.
1213L. Gong et al. / Biochimica et Biophysica Acta 1813 (2011) 1211–1219mannitol (Fig. 1D). Apoptotic cells showed the characteristic features
of condensed and coalesced nuclei on laser scanning confocal
microscopy (Fig. 1C).
Because the JNK signaling pathway and RNS play an important role
in hyperglycemia-induced endothelium apoptosis [10–12], we exam-
ined the effects of the JNK inhibitor SP600125 (30 μmol/l) and iNOS
inhibitor 1400W (20 μmol/l) on the apoptotic rate of MS-1 cells
treated with high glucose. Pretreatment with SP600125 under high
glucose signiﬁcantly reduced the percentage apoptosis as compared
with high glucose (10.0% vs.15.2% by annexin-V and PI double
staining; Pb0.05; and 9.7% vs.19.2% by Hoechst 33258 staining;
Pb0.05) (Fig. 1B, D). Results were similar with 1400W pretreatment
under high glucose as compared with high glucose (9.4% vs. 15.2% by
annexin-V and PI double staining; Pb0.05; and 10.3% vs.19.2% by
Hoechst 33258 staining; Pb0.05) (Fig. 1B, D).Caspases are very important regulators of apoptosis, especially
caspase-3 which is a marker of apoptosis. Activity of caspase-3 was
signiﬁcantly increased after high glucose treatment which was time-
dependent, as compared with normal glucose (Pb0.05) (Fig. 1E).
Pretreatmentwith SP600125 or 1400Wunder high glucose signiﬁcantly
reduced the activity of caspase-3 as compared with high glucose
(Pb0.05) (Fig. 1E).
3.2. Inhibition of JNK or iNOS represses the protein expression of iNOS
and nitrotyrosine and production of NO induced by hyperglycemia
To elucidate the signaling pathways involved in apoptosis with
hyperglycemia, we examined the protein expression of iNOS and
nitrotyrosine and production of NO induced by hyperglycemia. MS-1
cells were pretreated with or without SP600125 or 1400W for 1 h and
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iNOS and nitrotyrosine in MS-1 cells was signiﬁcantly higher with high
than normal glucose treatment on western blot analysis (Pb0.05)
(Fig. 2A, B, C, D). A similar result was observed by immunocytochemistry
of iNOS (Pb0.05) (Fig. 2E, F). Treatment with SP600125 or 1400W
effectively reversed the high iNOS protein expression induced by
hyperglycemia by 45.1% (Pb0.05) and 23.8% (Pb0.05), respectively,
and nitrotyrosine expression by 47.0% (Pb0.05) and 27.7% (Pb0.05),
respectively (Fig. 2A, B, C, D). Similar to western blot analysis,
immunocytochemistry revealed that as compared with high glucoseFig. 2. Inhibition of JNK or iNOS represses the expression of iNOS and nitrotyrosine and pro
SP600125 (30 μmol/l) or 1400W (20 μmol/l) for 1 h before high glucose for 7 days. (A) The p
(B) Quantitative analysis of iNOS (n=3, means±S.D.). *Pb0.05 vs. 5.5 mM, #Pb0.05 vs. 30 m
protein level of nitrotyrosine was examined by western blot analysis with the indicated a
5.5 mM, #Pb0.05 vs. 30 mM. (E) Fluorescent micrographs showing the relative level of iNOS.
glucose 5.5 mmol/l) in MS-1 cells. (n=5, means±S.D.). *Pb0.05 vs. 5.5 mM, #Pb0.05 vs. 30
high glucose for different times in the previous 2 days. (n=5, means±S.D.). At 48 h, *Pb0treatment alone, pretreatment with SP600125 or 1400W decreased the
expression of iNOS (Pb0.05) (Fig. 2E, F).
Total NO(NO2− and NO3−) in the culture media, with or without the
inhibitors, was measured at different time points in the previous
2 days, including 1 h, 6 h, 12 h, 24 h, 48 h. The release of NO in the
culture medium was signiﬁcantly higher with high than normal
glucose treatment at 48 h (Pb0.05). Consistent with iNOS expression,
hyperglycemia-increased NO production in culture medium was
decreased with SP600125 or 1400W pretreatment at 48 h (Pb0.05)
(Fig. 2G).duction of NO induced by hyperglycemia. MS-1 cells were pretreated with or without
rotein level of iNOS was examined by western blot analysis with the indicated antibody.
M. (C) The presence of nitrotyrosine used as a marker for peroxynitrite formation. The
ntibody. (D) Quantitative analysis of nitrotyrosine (n=3, means±S.D.). *Pb0.05 vs.
(F) Quantitative analysis of iNOS expressed as fold increase over control group (normal
mM. (G) Total NO (NO2− and NO3−) in the culture media collected from cells exposed to
.05 vs. 5.5 mM, #Pb0.05 vs. 30 mM. Bar=20 μm.
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MS-1 cells
The production of intracellular ROS and O2− was signiﬁcantly
increased in MS-1 cells with high glucose (Pb0.05) but not
hyperosmotic control treatment (PN0.05) (Fig. 3).
3.4. Inhibition iNOS attenuates hyperglycemia-induced apoptosis by
inhibiting JNK activity
To test whether the JNK signaling pathway is involved in hypergly-
cemia-induced apoptosis, we examined the effect of high glucose on the
phosphorylation of JNK by western blot analysis. JNK was markedly
phosphorylated with sustained high-glucose stimulation, with no
change in total JNK level (Pb0.05) (Fig. 4A, B). Importantly, adminis-
tration of the speciﬁc inhibitor of iNOS, 1400W, completely attenuated
phosphorylated JNK (P-JNK) level (Pb0.05) (Fig. 4C, D) and MS-1 cell
apoptosis induced by high glucose (Pb0.05) (Fig. 1). Similar to western
blot analysis, immunocytochemistry revealed that pretreatment with
1400W decreased P-JNK level in MS-1 cells (Pb0.05) (Fig. 4E, F). The
effect of 1400Wwas similarwith that of SP600125, a speciﬁc inhibitor of
JNK, on P-JNK level in high glucose(PN0.05) (Fig. 4C, D, E, F).
3.5. High glucose regulates the expression of bax and bcl-2 via JNK activation
To determinewhether hyperglycemia alters the intrinsic-dependent
apoptotic pathway in MS-1 cells, we examined the expression of theFig. 3. Effect of high glucose on the production of intracellular ROS and O2− in MS-1 cells. (A)
ROS expressed as fold increase over the control (normal glucose 5.5 mmol/l). (n=5, means
the relative level of O2−. (D) Quantitative analysis of O2− expressed as fold increase over the c
vs. 5.5 mM. Bar=20 μm.pro-apoptotic protein bax and anti-apoptotic protein bcl-2. Interesting-
ly, high glucose treatment signiﬁcantly increased bax protein level, with
no signiﬁcant change in bcl-2 protein level (Pb0.05) (Fig. 5A, B). This
change was attenuated in MS-1 cells pretreated with SP600125 under
high glucose (Pb0.05) (Fig. 5A, B). Furthermore, the ratio of bax to bcl-2,
which was higher with high than normal glucose treatment, was
attenuated by SP600125 (Pb0.05) (Fig. 5C).
3.6. High glucose regulates the expression of cleaved caspase-3 and PARP
by JNK activation
We next examined whether high glucose regulates the cleavage of
caspase-3 and PARP by JNK activation. The protein levels of cleaved
caspase-3 and PARP were signiﬁcantly higher with high than normal
glucose treatment as determined by western blot analysis (Pb0.05).
However, SP600125 treatment decreased the levels of cleaved
caspase-3 and PARP induced by high glucose (Pb0.05) (Fig. 5D, E).
4. Discussion
Hyperglycemia signiﬁcantly stimulates pancreatic islet EC apoptosis;
however, theprecisemechanismsarenot fullyunderstood. In thepresent
study, we analyzed the effects of hyperglycemia on islet EC (MS-1)
apoptosis and evaluated the production of iNOS, NO and ONOO−. In
addition, we investigated whether the JNK pathway or an intrinsic-
dependent apoptotic pathway plays a role in islet EC apoptosis. The
principal ﬁndings of this study are threefold: 1) hyperglycemia-inducedFluorescent micrographs showing the relative level of ROS. (B) Quantitative analysis of
±S.D.). *Pb0.05 vs. 5.5 mM, #PN0.05 vs. 5.5 mM. (C) Fluorescent micrographs showing
ontrol (normal glucose 5.5 mmol/l). (n=5, means±S.D.). *Pb0.05 vs. 5.5 mM, #PN0.05
Fig. 4. Inhibition of iNOS attenuates the phosphorylation of JNK induced by hyperglycemia in MS-1 cells. (A) MS-1 cells maintained under high glucose (30 mmol/l). The protein
levels of phosphorylated JNK (P-JNK) and total JNK (T-JNK) under high glucose (30 mmol/l) were examined by western blot analysis at different times. (B) Quantitative analysis of
P-JNK (n=3,means±S.D.). *Pb0.05 vs.0. (C) MS-1 cells were pretreated with or without SP600125 (30 μmol/l) or 1400W (20 μmol/l) for 1 h before exposure to high glucose for 6 h.
The protein levels of P-JNK and T-JNK were examined by western blot analysis with indicated antibodies. (D) Quantitative analysis of P-JNK (n=3, means±S.D.). *Pb0.05 vs.
5.5 mM, #Pb0.05 vs. 30 mM, □PN0.05 vs. 30+SP. (E) Fluorescent micrographs showing the level of P-JNK with treatment. (F) Quantitative analysis of P-JNK was expressed as fold
increase over controls (normal glucose 5.5 mmol/l) in MS-1 cells. (n=5, means±S.D.). *Pb0.05 vs. 5.5 mM, #Pb0.05 vs. 30 mM, □ PN0.05 vs. 30+SP. Bar=20 μm.
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apoptotic pathway as seen by the effect on the expression of the pro-
apoptotic proteinbax; 2) reductionofRNS level can completely attenuate
phosphorylation of JNK in hyperglycemia; and 3) incubation with a JNK
inhibitor, SP600125, can decrease bax level and cleaved caspase-3
production and prevent MS-1 cells from apoptosis with sustained
hyperglycemia, which suggests that the pro-apoptotic effect of RNS is
mediated by JNK in hyperglycemia. Therefore, hyperglycemia-inducedapoptosis in MS-1 cells activates an intrinsic-dependent apoptotic
pathway by RNS-mediated JNK activation (Fig. 6).
The pancreatic islet endothelium is involved in the physiological
function and disease pathogenesis of the pancreas and has an
interdependent relationship with neighboring B cells [4]. Many
studies have demonstrated that hyperglycemia can induce EC
apoptosis [11,13,18–20]. The mechanisms of hyperglycemia-induced
apoptosis in the endothelium are well understood and include
Fig. 5. High glucose regulates expression of bax, bcl-2, cleaved caspase-3 and cleaved poly adenosine diphosphate (ADP)-ribose polymerase (PARP) by JNK activation. MS-1 cells were
pretreated or not with SP600125 (30 μmol/l) for 1 h before exposure to normal glucose (5.5 mmol/l) or high glucose (30 mmol/l) for 12 h. (A) The protein levels of bax and bcl-2 were
examined bywestern blot analysis with indicated antibodies. (B) Quantitative analysis of bax and bcl-2 (n=3,means±S.D.). *Pb0.05 vs. 5.5 mM, #Pb0.05 vs. 30 mM. (C) Quantitative
analysis of ratio of bax to bcl-2 (n=3, means±S.D.). *Pb0.05 vs. 5.5 mM, #Pb0.05 vs. 30 mM. (D) The protein levels of cleaved caspase-3 and PARP were examined by western blot
analysis with indicated antibodies. (E) Quantitative analysis of cleaved caspase-3 and PARP (n=3, means±S.D.). *Pb0.05 vs. 5.5 mM, #Pb0.05 vs. 30 mM.
Fig. 6. Potential mechanisms of MS-1 cell apoptosis induced by high glucose. Hyperglycemia signiﬁcantly stimulates the expression of iNOS and the production of NO and O2−, thus
resulting in excess production of ONOO−, which activates the JNK pathway. High glucose increases the protein level of pro-apoptotic bax without affecting that of anti-apoptotic
bcl-2 via the JNK pathway, thus resulting in activation of the caspase cascade. Activation of the caspase cascade cleaves PARP in nuclei, thus leading to MS-1 cell apoptosis.
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of endoplasmic reticulum stress, changes in intracellular fatty acid
metabolism, lipid peroxidation, and activation of extrinsic- or
intrinsic-dependent apoptotic pathways. Peroxynitrite, an important
member of RNS, is generated by the rapid reaction betweenNO and O2−,
and nucleic acids, lipids, and proteins are all targets of peroxynitrite-
mediated dysfunction and apoptosis [21,22]. Recent evidence indicates
that hyperglycemia causes peroxynitrite overproduction in ECs, which
triggers apoptosis via tyrosine nitration and inactivation of prostacyclin
synthase [11] and by inhibiting Akt signaling via ONOO−-mediated
LKB1-dependent PTEN (phosphatase and tensin homologue deleted on
chromosome 10) activation [12]. iNOS produces excess free radical NO,
which can be converted to RNS, includingperoxynitrite, under oxidative
circumstances [23]. In the present study, MS-1 cells under hyperglyce-
mia showed a signiﬁcant increase in iNOS expression, NO production,
intracellular ROS level, O2− production and nitrotyrosine expression,
which induced apoptosis of MS-1 cells. These effects induced by
hyperglycemia were markedly inhibited by treatment with 1400W, a
speciﬁc inhibitor of iNOS. These data demonstrate that hyperglycemia-
induced apoptosis in MS-1 cells is triggered by RNS.
MAPKs regulate numerous cellular processes such as proliferation,
differentiation, inﬂammation and apoptosis. Recent data provide
evidence that the JNK signaling pathway is involved in stress-induced
apoptosis in several cell lines [24]. JNK is activated by hyperglycemia
[10] and RNS [21,25], and its inhibition blocks apoptosis induced by
hyperglycemia or RNS. Consistent with these data, our results indicate
that the phosphorylation of JNK was increased in hyperglycemia, and
this effect wasmarkedly inhibited by treatmentwith the iNOS inhibitor
1400W or the JNK inhibitor SP600125. Furthermore, the inhibition of
JNK by 1400Wwas associated with a decrease in cleaved caspase-3 and
PARP and cell apoptosis. Therefore, RNS-induced cell apoptosis can be
inhibited by blocking activation of JNK in hyperglycemia.
Apoptosis induced by hyperglycemia may be largely controlled by
pro-apoptotic and anti-apoptotic molecules such as bax and bcl-2,
respectively. A recent study demonstrated that the expression of bax
was signiﬁcantly higher in type 2 diabetes mellitus, whereas that of
bcl-2 was signiﬁcantly higher in controls [26]. In the intrinsic-
dependent apoptotic pathway, the balance of pro-apoptotic proteins
(e.g., bax) and anti-apoptotic proteins (e.g., bcl-2) was found to
determine the response of cells to apoptotic stimuli [27]. As well, in
human aortic ECs [28] and human umbilical vein ECs, high glucose
signiﬁcantly increased bax but not bcl-2 protein level, thereby elevating
the ratio of bax to bcl-2, which activated caspase-3 and triggered
apoptosis [29]. Consistent with these data, the present study revealed a
signiﬁcant increase in bax but not bcl-2 protein level with high glucose
treatment. We demonstrated that apoptosis in MS-1 cells induced by
high glucose may be attributed to an inappropriate increase of the ratio
of bax to bcl-2 level. Furthermore, the JNK inhibitor SP600125 can
prevent the hyperglycemia-induced increase in the ratio of bax to bcl-2
level, activation of caspase-3 and PARP, and MS-1 cell apoptosis. Thus,
these results indicate that hyperglycemia-induced apoptosis is through
the intrinsic-dependent apoptotic pathway via JNK activation.
In conclusion, our studydemonstrated that activation of JNK signaling
is required for RNS-mediated bax protein production and caspase-3
activation and apoptosis in MS-1 cells induced by high glucose. These
ﬁndings offer an insight into the apoptotic processes in pancreatic islet
ECs in hyperglycemia. In addition, islet ECs represent a target for a novel
therapeutic strategy to improve islet vascularization in diabetes mellitus
and, indirectly, pancreas islet function. However, further investigations
are needed to understand the underlying mechanisms of the endothe-
lium in islet physiology and pathology in animal models.Disclosures
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